Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMDP) Minority Interest (2016 - 2025)

Historic Minority Interest for LifeMD (LFMDP) over the last 11 years, with Q3 2025 value amounting to $2.1 million.

  • LifeMD's Minority Interest rose 1635.98% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 1635.98%. This contributed to the annual value of $1.5 million for FY2024, which is 2580.05% down from last year.
  • Latest data reveals that LifeMD reported Minority Interest of $2.1 million as of Q3 2025, which was up 1635.98% from $2.2 million recorded in Q2 2025.
  • Over the past 5 years, LifeMD's Minority Interest peaked at $2.2 million during Q2 2025, and registered a low of -$1.1 million during Q3 2021.
  • Its 5-year average for Minority Interest is $572966.1, with a median of $783619.0 in 2023.
  • Its Minority Interest has fluctuated over the past 5 years, first plummeted by 14310.35% in 2021, then soared by 690769.28% in 2024.
  • Quarter analysis of 5 years shows LifeMD's Minority Interest stood at -$1.0 million in 2021, then soared by 53.91% to -$475548.0 in 2022, then surged by 533.35% to $2.1 million in 2023, then decreased by 25.8% to $1.5 million in 2024, then skyrocketed by 34.32% to $2.1 million in 2025.
  • Its last three reported values are $2.1 million in Q3 2025, $2.2 million for Q2 2025, and $1.9 million during Q1 2025.